The Opioid Crisis: A Lesson in Adaptation
Posted October 17, 2017| Tanya Chotibut
There is an over-reliance on opioid medications within the U.S., with alarming increases in diversion, overdose, and addiction and it has created the opioid epidemic.
This whitepaper outlines the opioid epidemics and the related issues for pharma companies while offering a high-level solution for pharma companies to consider as they move products through the life-cycle. Solutions are not limited to post-marketing surveillance and implementing adaptive trials with more data integration and the use of predictive analytics.
Download the Whitepaper:
Tags: BioPharma, Growth Analytics, Health + Life Science, Market Analysis, Scenario Planning
